Towards global consensus on outcome measures for atopic eczema research: Results of the HOME II meeting

Jochen Schmitt, Phyllis Spuls, Maarten Boers, Kim Thomas, Joanne Chalmers, Evelien Roekevisch, Mandy Schram, Richard Allsopp, Valeria Aoki, Christian Apfelbacher, Carla Bruijnzeel-Koomen, Marjolein Bruin-Weller, Carolyn Charman, Arnon Cohen, Magdalene Dohil, Carsten Flohr, Masutaka Furue, Uwe Gieler, Lotty Hooft, Rosemary HumphreysHenrique Akira Ishii, Ichiro Katayama, Willem Kouwenhoven, Sinéad Langan, Sue Lewis-Jones, Stephanie Merhand, Hiroyuki Murota, Dedee F. Murrell, Helen Nankervis, Yukihiro Ohya, Arnold Oranje, Hiromi Otsuka, Carle Paul, Yael Rosenbluth, Hidehisa Saeki, Marie Louise Schuttelaar, Jean Francois Stalder, Ãke Svensson, Roberto Takaoka, Carl Fredrik Wahlgren, Stephan Weidinger, Andreas Wollenberg, Hywel Williams

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

The use of nonstandardized and inadequately validated outcome measures in atopic eczema trials is a major obstacle to practising evidence-based dermatology. The Harmonising Outcome Measures for Eczema (HOME) initiative is an international multiprofessional group dedicated to atopic eczema outcomes research. In June 2011, the HOME initiative conducted a consensus study involving 43 individuals from 10 countries, representing different stakeholders (patients, clinicians, methodologists, pharmaceutical industry) to determine core outcome domains for atopic eczema trials, to define quality criteria for atopic eczema outcome measures and to prioritize topics for atopic eczema outcomes research. Delegates were given evidence-based information, followed by structured group discussion and anonymous consensus voting. Consensus was achieved to include clinical signs, symptoms, long-term control of flares and quality of life into the core set of outcome domains for atopic eczema trials. The HOME initiative strongly recommends including and reporting these core outcome domains as primary or secondary endpoints in all future atopic eczema trials. Measures of these core outcome domains need to be valid, sensitive to change and feasible. Prioritized topics of the HOME initiative are the identification/development of the most appropriate instruments for the four core outcome domains. HOME is open to anyone with an interest in atopic eczema outcomes research.

Original languageEnglish
Pages (from-to)1111-1117
Number of pages7
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume67
Issue number9
DOIs
Publication statusPublished - Sep 1 2012

Fingerprint

Eczema
Atopic Dermatitis
Outcome Assessment (Health Care)
Research
Drug Industry
Politics
Dermatology
Signs and Symptoms
Quality of Life

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Towards global consensus on outcome measures for atopic eczema research : Results of the HOME II meeting. / Schmitt, Jochen; Spuls, Phyllis; Boers, Maarten; Thomas, Kim; Chalmers, Joanne; Roekevisch, Evelien; Schram, Mandy; Allsopp, Richard; Aoki, Valeria; Apfelbacher, Christian; Bruijnzeel-Koomen, Carla; Bruin-Weller, Marjolein; Charman, Carolyn; Cohen, Arnon; Dohil, Magdalene; Flohr, Carsten; Furue, Masutaka; Gieler, Uwe; Hooft, Lotty; Humphreys, Rosemary; Ishii, Henrique Akira; Katayama, Ichiro; Kouwenhoven, Willem; Langan, Sinéad; Lewis-Jones, Sue; Merhand, Stephanie; Murota, Hiroyuki; Murrell, Dedee F.; Nankervis, Helen; Ohya, Yukihiro; Oranje, Arnold; Otsuka, Hiromi; Paul, Carle; Rosenbluth, Yael; Saeki, Hidehisa; Schuttelaar, Marie Louise; Stalder, Jean Francois; Svensson, Ãke; Takaoka, Roberto; Wahlgren, Carl Fredrik; Weidinger, Stephan; Wollenberg, Andreas; Williams, Hywel.

In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 67, No. 9, 01.09.2012, p. 1111-1117.

Research output: Contribution to journalArticle

Schmitt, J, Spuls, P, Boers, M, Thomas, K, Chalmers, J, Roekevisch, E, Schram, M, Allsopp, R, Aoki, V, Apfelbacher, C, Bruijnzeel-Koomen, C, Bruin-Weller, M, Charman, C, Cohen, A, Dohil, M, Flohr, C, Furue, M, Gieler, U, Hooft, L, Humphreys, R, Ishii, HA, Katayama, I, Kouwenhoven, W, Langan, S, Lewis-Jones, S, Merhand, S, Murota, H, Murrell, DF, Nankervis, H, Ohya, Y, Oranje, A, Otsuka, H, Paul, C, Rosenbluth, Y, Saeki, H, Schuttelaar, ML, Stalder, JF, Svensson, Ã, Takaoka, R, Wahlgren, CF, Weidinger, S, Wollenberg, A & Williams, H 2012, 'Towards global consensus on outcome measures for atopic eczema research: Results of the HOME II meeting', Allergy: European Journal of Allergy and Clinical Immunology, vol. 67, no. 9, pp. 1111-1117. https://doi.org/10.1111/j.1398-9995.2012.02874.x
Schmitt, Jochen ; Spuls, Phyllis ; Boers, Maarten ; Thomas, Kim ; Chalmers, Joanne ; Roekevisch, Evelien ; Schram, Mandy ; Allsopp, Richard ; Aoki, Valeria ; Apfelbacher, Christian ; Bruijnzeel-Koomen, Carla ; Bruin-Weller, Marjolein ; Charman, Carolyn ; Cohen, Arnon ; Dohil, Magdalene ; Flohr, Carsten ; Furue, Masutaka ; Gieler, Uwe ; Hooft, Lotty ; Humphreys, Rosemary ; Ishii, Henrique Akira ; Katayama, Ichiro ; Kouwenhoven, Willem ; Langan, Sinéad ; Lewis-Jones, Sue ; Merhand, Stephanie ; Murota, Hiroyuki ; Murrell, Dedee F. ; Nankervis, Helen ; Ohya, Yukihiro ; Oranje, Arnold ; Otsuka, Hiromi ; Paul, Carle ; Rosenbluth, Yael ; Saeki, Hidehisa ; Schuttelaar, Marie Louise ; Stalder, Jean Francois ; Svensson, Ãke ; Takaoka, Roberto ; Wahlgren, Carl Fredrik ; Weidinger, Stephan ; Wollenberg, Andreas ; Williams, Hywel. / Towards global consensus on outcome measures for atopic eczema research : Results of the HOME II meeting. In: Allergy: European Journal of Allergy and Clinical Immunology. 2012 ; Vol. 67, No. 9. pp. 1111-1117.
@article{e0d91eacf1a24772a8368967fa66c725,
title = "Towards global consensus on outcome measures for atopic eczema research: Results of the HOME II meeting",
abstract = "The use of nonstandardized and inadequately validated outcome measures in atopic eczema trials is a major obstacle to practising evidence-based dermatology. The Harmonising Outcome Measures for Eczema (HOME) initiative is an international multiprofessional group dedicated to atopic eczema outcomes research. In June 2011, the HOME initiative conducted a consensus study involving 43 individuals from 10 countries, representing different stakeholders (patients, clinicians, methodologists, pharmaceutical industry) to determine core outcome domains for atopic eczema trials, to define quality criteria for atopic eczema outcome measures and to prioritize topics for atopic eczema outcomes research. Delegates were given evidence-based information, followed by structured group discussion and anonymous consensus voting. Consensus was achieved to include clinical signs, symptoms, long-term control of flares and quality of life into the core set of outcome domains for atopic eczema trials. The HOME initiative strongly recommends including and reporting these core outcome domains as primary or secondary endpoints in all future atopic eczema trials. Measures of these core outcome domains need to be valid, sensitive to change and feasible. Prioritized topics of the HOME initiative are the identification/development of the most appropriate instruments for the four core outcome domains. HOME is open to anyone with an interest in atopic eczema outcomes research.",
author = "Jochen Schmitt and Phyllis Spuls and Maarten Boers and Kim Thomas and Joanne Chalmers and Evelien Roekevisch and Mandy Schram and Richard Allsopp and Valeria Aoki and Christian Apfelbacher and Carla Bruijnzeel-Koomen and Marjolein Bruin-Weller and Carolyn Charman and Arnon Cohen and Magdalene Dohil and Carsten Flohr and Masutaka Furue and Uwe Gieler and Lotty Hooft and Rosemary Humphreys and Ishii, {Henrique Akira} and Ichiro Katayama and Willem Kouwenhoven and Sin{\'e}ad Langan and Sue Lewis-Jones and Stephanie Merhand and Hiroyuki Murota and Murrell, {Dedee F.} and Helen Nankervis and Yukihiro Ohya and Arnold Oranje and Hiromi Otsuka and Carle Paul and Yael Rosenbluth and Hidehisa Saeki and Schuttelaar, {Marie Louise} and Stalder, {Jean Francois} and {\~A}ke Svensson and Roberto Takaoka and Wahlgren, {Carl Fredrik} and Stephan Weidinger and Andreas Wollenberg and Hywel Williams",
year = "2012",
month = "9",
day = "1",
doi = "10.1111/j.1398-9995.2012.02874.x",
language = "English",
volume = "67",
pages = "1111--1117",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Towards global consensus on outcome measures for atopic eczema research

T2 - Results of the HOME II meeting

AU - Schmitt, Jochen

AU - Spuls, Phyllis

AU - Boers, Maarten

AU - Thomas, Kim

AU - Chalmers, Joanne

AU - Roekevisch, Evelien

AU - Schram, Mandy

AU - Allsopp, Richard

AU - Aoki, Valeria

AU - Apfelbacher, Christian

AU - Bruijnzeel-Koomen, Carla

AU - Bruin-Weller, Marjolein

AU - Charman, Carolyn

AU - Cohen, Arnon

AU - Dohil, Magdalene

AU - Flohr, Carsten

AU - Furue, Masutaka

AU - Gieler, Uwe

AU - Hooft, Lotty

AU - Humphreys, Rosemary

AU - Ishii, Henrique Akira

AU - Katayama, Ichiro

AU - Kouwenhoven, Willem

AU - Langan, Sinéad

AU - Lewis-Jones, Sue

AU - Merhand, Stephanie

AU - Murota, Hiroyuki

AU - Murrell, Dedee F.

AU - Nankervis, Helen

AU - Ohya, Yukihiro

AU - Oranje, Arnold

AU - Otsuka, Hiromi

AU - Paul, Carle

AU - Rosenbluth, Yael

AU - Saeki, Hidehisa

AU - Schuttelaar, Marie Louise

AU - Stalder, Jean Francois

AU - Svensson, Ãke

AU - Takaoka, Roberto

AU - Wahlgren, Carl Fredrik

AU - Weidinger, Stephan

AU - Wollenberg, Andreas

AU - Williams, Hywel

PY - 2012/9/1

Y1 - 2012/9/1

N2 - The use of nonstandardized and inadequately validated outcome measures in atopic eczema trials is a major obstacle to practising evidence-based dermatology. The Harmonising Outcome Measures for Eczema (HOME) initiative is an international multiprofessional group dedicated to atopic eczema outcomes research. In June 2011, the HOME initiative conducted a consensus study involving 43 individuals from 10 countries, representing different stakeholders (patients, clinicians, methodologists, pharmaceutical industry) to determine core outcome domains for atopic eczema trials, to define quality criteria for atopic eczema outcome measures and to prioritize topics for atopic eczema outcomes research. Delegates were given evidence-based information, followed by structured group discussion and anonymous consensus voting. Consensus was achieved to include clinical signs, symptoms, long-term control of flares and quality of life into the core set of outcome domains for atopic eczema trials. The HOME initiative strongly recommends including and reporting these core outcome domains as primary or secondary endpoints in all future atopic eczema trials. Measures of these core outcome domains need to be valid, sensitive to change and feasible. Prioritized topics of the HOME initiative are the identification/development of the most appropriate instruments for the four core outcome domains. HOME is open to anyone with an interest in atopic eczema outcomes research.

AB - The use of nonstandardized and inadequately validated outcome measures in atopic eczema trials is a major obstacle to practising evidence-based dermatology. The Harmonising Outcome Measures for Eczema (HOME) initiative is an international multiprofessional group dedicated to atopic eczema outcomes research. In June 2011, the HOME initiative conducted a consensus study involving 43 individuals from 10 countries, representing different stakeholders (patients, clinicians, methodologists, pharmaceutical industry) to determine core outcome domains for atopic eczema trials, to define quality criteria for atopic eczema outcome measures and to prioritize topics for atopic eczema outcomes research. Delegates were given evidence-based information, followed by structured group discussion and anonymous consensus voting. Consensus was achieved to include clinical signs, symptoms, long-term control of flares and quality of life into the core set of outcome domains for atopic eczema trials. The HOME initiative strongly recommends including and reporting these core outcome domains as primary or secondary endpoints in all future atopic eczema trials. Measures of these core outcome domains need to be valid, sensitive to change and feasible. Prioritized topics of the HOME initiative are the identification/development of the most appropriate instruments for the four core outcome domains. HOME is open to anyone with an interest in atopic eczema outcomes research.

UR - http://www.scopus.com/inward/record.url?scp=84864977670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864977670&partnerID=8YFLogxK

U2 - 10.1111/j.1398-9995.2012.02874.x

DO - 10.1111/j.1398-9995.2012.02874.x

M3 - Article

C2 - 22844983

AN - SCOPUS:84864977670

VL - 67

SP - 1111

EP - 1117

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 9

ER -